Testing effectiveness (Phase 2)WithdrawnNCT01293942What this trial is testingIXO+A in mCRC With Liver-only MetastasesWho this might be right forMetastatic Colorectal Cancer Ottawa Hospital Research Institute
Testing effectiveness (Phase 2)Looking for participantsNCT05954429What this trial is testingExplore the Third-line Treatment of Fruquintinib Combined With Serplulimab in Advanced Non-liver-limited Metastatic Colorectal Cancer: a Single-center, Phase 2 StudyWho this might be right forColorectal Cancer Fudan University 50
Testing effectiveness (Phase 2)Ended earlyNCT06834399What this trial is testingTATE and KN046 in MCRCWho this might be right forColorectal Cancer with Hepatic Metastases Zhejiang Raygene Pharmaceuticals Co., Ltd 42
Early research (Phase 1)Study completedNCT01638533What this trial is testingRomidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionWho this might be right forGliomaHematopoietic and Lymphoid Cell NeoplasmLymphoma+47 more National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802876What this trial is testingEfficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing TumorsWho this might be right forMSI-H Colorectal CancerMelanomaAnal Carcinoma+28 more SOLTI Breast Cancer Research Group 184
Testing effectiveness (Phase 2)Ended earlyNCT04508140What this trial is testingStudy of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver MetastasisWho this might be right forColorectal CancerGastric CancerOesophageal Cancer Highlight Therapeutics 18
Very early researchEnded earlyNCT00499733What this trial is testingCyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Study completedNCT03602079What this trial is testingStudy of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneWho this might be right forHER2-positive Breast CancerHER2 Gene MutationHER-2 Gene Amplification+41 more Klus Pharma Inc. 49
Not applicableStudy completedNCT00003186What this trial is testingDiagnostic Procedure for Identifying Patients With Metastatic Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer Roswell Park Cancer Institute
Early research (Phase 1)Ended earlyNCT02559024What this trial is testingAnti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal CancerWho this might be right forColorectal Neoplasms Providence Health & Services 4
Large-scale testing (Phase 3)UnknownNCT03783559What this trial is testingTACE(Transcatheter Arterial Chemoembolization ) Associated With Systemic Chemotherapy Versus Systemic Chemotherapy Alone in Patients With Unresectable CRLM(Colorectal Liver Metastases)Who this might be right forColorectal Adenocarcinoma Metastatic to the Liver Fudan University 168
Not applicableStudy completedNCT04028479What this trial is testingThe Registry of Oncology Outcomes Associated With Testing and TreatmentWho this might be right forAdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more Taproot Health 167
Testing effectiveness (Phase 2)Active Not RecruitingNCT05620134What this trial is testingStudy of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerWho this might be right forCancerTumor, SolidAdvanced Solid Tumor+19 more Salubris Biotherapeutics Inc 263
Testing effectiveness (Phase 2)WithdrawnNCT04430985What this trial is testingFOLFOX + Immunotherapy With Intrahepatic Oxaliplatin for Patients With Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Dorte Nielsen
Testing effectiveness (Phase 2)Ended earlyNCT00537823What this trial is testingPre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver InvolvementWho this might be right forColorectal CancerMetastases Washington University School of Medicine 9
Testing effectiveness (Phase 2)UnknownNCT05103020What this trial is testingPhase II Study Comparing Conversion Rate to Surgery With Hepatic Arterial Infusion Chemotherapy to Systemic Chemotherapy in Patients With Non Resectable Liver-only Colorectal MetastasesWho this might be right forMetastatic Colorectal Cancer Yonsei University 100
Not applicableStudy completedNCT01736813What this trial is testingCCR5-blockade in Metastatic Colorectal CancerWho this might be right forColorectal CancerNeoplasm MetastasisLiver Metastases National Center for Tumor Diseases, Heidelberg 12
Not applicableStudy completedNCT01460745What this trial is testingA Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical PracticeWho this might be right forMetastatic Colorectal Cancer Merck KGaA, Darmstadt, Germany 60
Early research (Phase 1)Study completedNCT02298946What this trial is testingAMP-224, a PD-1 Inhibitor, With Stereotactic Body Radiation Therapy in Metastatic Colorectal CancerWho this might be right forColorectal CancerColorectal NeoplasmsColorectal Carcinoma National Cancer Institute (NCI) 17
Not applicableLooking for participantsNCT05787197What this trial is testingCtDNA in CRC Patients Undergoing Curative-intent Surgery for Liver MetastasesWho this might be right forMetastatic Colorectal CancerCirculating Tumor DNA GERCOR - Multidisciplinary Oncology Cooperative Group 232